Hoe verhoudt XRF's PE Ratio zich tot zijn concurrenten?

XRF is duur op basis van de Price-To-Earnings -ratio ( 25.3 x) vergeleken met het gemiddelde van de peer ( 23.1 x).

Hoe verhoudt XRF's PE Ratio zich tot andere bedrijven in de Global Machinery industrie?

XRF is duur op basis van de Price-To-Earnings -ratio ( 25.3 x) vergeleken met het Australian Machinery -industriegemiddelde ( 19.5 x).

Wat is XRF's PE Ratio vergeleken met zijn Fair PE Ratio? Dit is de verwachte PE Ratio, rekening houdend met de verwachte winstgroei van het bedrijf, winstmarges en andere risicofactoren.

XRF is duur op basis van de Price-To-Earnings Ratio ( 25.3 x) vergeleken met de geschatte Fair Price-To-Earnings Ratio ( 16.6 x).

Wat is de reële prijs van XRF als we kijken naar de toekomstige kasstromen? Voor deze schatting gebruiken we een Discounted Cash Flow-model.

XRF ( A$1.6 ) wordt verhandeld onder onze schatting van [[eerlijke waarde]] ( A$2.22 )

Wat is de 12-maandsprognose van de analisten en hebben we enig statistisch vertrouwen in het consensuskoersdoel?

Er zijn onvoldoende gegevens om een prijsvoorspelling te tonen.

XRF Scientific (ASX:XRF) - Aandelenkoers, Nieuws & Analyse

XRF Overzicht aandelen

Over het bedrijf

XRF fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	2/6
Prestaties in het verleden	4/6
Financiële gezondheid	6/6
Dividenden	3/6

Beloningen

Verhandeld tegen 27.9% onder onze schatting van de reële waarde

De winst zal naar verwachting met 11.83% per jaar groeien

De winst groeide het afgelopen jaar met 15.6%

Risicoanalyse

XRF onze risicocontroles hebben doorstaan.

XRF Scientific Limited Concurrenten

VEEM

ASX:VEE

AU$200.9m

Environmental Group

ASX:EGL

AU$145.5m

Korvest

ASX:KOV

AU$107.4m

LaserBond

ASX:LBL

AU$72.7m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor XRF Scientific
Historische aandelenkoersen
Huidige aandelenkoers	AU$1.60
52 Week Hoogtepunt	AU$1.75
52 Week Laag	AU$0.95
Bèta	0.89
11 maand verandering	-2.14%
3 maanden verandering	18.96%
1 Jaar Verandering	59.20%
33 jaar verandering	146.15%
5 jaar verandering	580.85%
Verandering sinds IPO	644.19%

Recent nieuws en updates

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21

Recent updates

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Aug 21

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

Oct 05

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

Sep 19

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

Aug 22

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Feb 01

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Oct 19

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

May 12

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

Apr 21

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Oct 01

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

May 18

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

Apr 19

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

Mar 17

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Mar 01

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Feb 17

Our View On XRF Scientific's (ASX:XRF) CEO Pay

Jan 27

Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

Jan 12

XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 23

XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

Dec 10

The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

Nov 25

Rendement voor aandeelhouders

	XRF	AU Machinery	AU Markt
7D	-3.6%	-1.6%	-1.1%
1Y	59.2%	44.0%	16.1%

Rendement versus industrie: XRF overtrof de Australian Machinery industrie, die het afgelopen jaar een rendement 44 % opleverde.

Rendement versus markt: XRF overtrof de Australian markt, die het afgelopen jaar een rendement opleverde van 16.1 %.

Prijsvolatiliteit

Is XRF's price volatile compared to industry and market?
XRF volatility
XRF Average Weekly Movement	5.3%
Machinery Industry Average Movement	7.4%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.5%
10% least volatile stocks in AU Market	3.6%

Stabiele aandelenkoers: XRF heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van XRF is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1972	n/a	Vance Stazzonelli	www.xrfscientific.com

XRF Scientific Limited produceert en verkoopt edelmetaalproducten, gespecialiseerde chemicaliën en instrumenten voor de wetenschappelijke, analytische, bouwmaterialen- en mijnbouwindustrie in Australië, Canada en Europa. Het bedrijf is actief via de segmenten Kapitaalgoederen, Edelmetalen en Verbruiksgoederen. Het segment Kapitaalgoederen produceert geautomatiseerde fusieapparatuur, hoge temperatuur test- en productieovens, laboratorium kaakbrekers en algemene laboratoriumapparatuur.

XRF Scientific Limited Samenvatting

Hoe verhouden de winst en inkomsten van XRF Scientific zich tot de beurswaarde?
XRF fundamentele statistieken
Marktkapitalisatie	AU$224.64m
Inkomsten(TTM)	AU$8.89m
Inkomsten(TTM)	AU$60.12m

25.3x

Koers/Winstverhouding

3.7x

P/S-verhouding

Is XRF overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
XRF resultatenrekening (TTM)
Inkomsten	AU$60.12m
Kosten van inkomsten	AU$33.57m
Brutowinst	AU$26.55m
Overige uitgaven	AU$17.66m
Inkomsten	AU$8.89m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.063
Brutomarge	44.16%
Nettowinstmarge	14.78%
Schuld/Eigen Vermogen Verhouding	5.3%

Hoe presteerde XRF op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.4%

Huidig dividendrendement

60%

Uitbetalingsratio

XRF Overzicht aandelen

Beloningen

Risicoanalyse

XRF Scientific Limited Concurrenten

ASX:VEE

AU$200.9m

ASX:EGL

AU$145.5m

ASX:KOV

AU$107.4m

ASX:LBL

AU$72.7m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Price target increased by 8.0% to AU$1.75

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

Upcoming dividend of AU$0.039 per share

XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Full year 2024 earnings: EPS and revenues exceed analyst expectations

Recent updates

Price target increased by 8.0% to AU$1.75

XRF Scientific Limited, Annual General Meeting, Oct 21, 2024

Upcoming dividend of AU$0.039 per share

XRF Scientific Limited Announces Ordinary Full Franked Dividend for the Twelve Months Ended June 30, 2024, Payment Date of September 27, 2024

Analysts Have Made A Financial Statement On XRF Scientific Limited's (ASX:XRF) Annual Report

Full year 2024 earnings: EPS and revenues exceed analyst expectations

XRF Scientific Limited (ASX:XRF) completed the acquisition of remaining 50% stake in Orbis Mining Pty. Ltd. for AUD 3.8 million.

Now 22% undervalued

Price target increased by 19% to AU$1.55

XRF Scientific Limited to Report Fiscal Year 2024 Results on Aug 20, 2024

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 24% undervalued

Now 25% undervalued

Now 23% undervalued

Now 23% undervalued

Now 22% undervalued

Now 20% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

Now 21% undervalued

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

New minor risk - Market cap size

Investor sentiment improves as stock rises 15%

Now 22% undervalued after recent price drop

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

XRF Scientific Limited, Annual General Meeting, Oct 31, 2023

Upcoming dividend of AU$0.033 per share at 3.0% yield

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

New minor risk - Dividend sustainability

Full year 2023 earnings: EPS and revenues miss analyst expectations

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

XRF Scientific Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2023, Payment Date of October 13, 2023

Non-Executive Director recently bought AU$89k worth of stock

New minor risk - Market cap size

Investor sentiment improves as stock rises 19%

Non-Executive Director recently bought AU$61k worth of stock

Investor sentiment improves as stock rises 18%

Now 23% undervalued

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Insufficient new directors

Now 21% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

XRF Scientific Limited Announces Dividend That Relates to the Financial Reporting or Payment Period Ended on June 30, 2022, Payable on October 14, 2022

Upcoming dividend of AU$0.025 per share

XRF Scientific Limited, Annual General Meeting, Oct 21, 2022

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

XRF Scientific Limited Announces Fully Franked Ordinary Dividend for the Year Ended June 30, 2022, Payable on 14 October 2022

Now 20% undervalued

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

Now 24% undervalued

Price target increased to AU$0.65

Insufficient new directors

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue